Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Shares Issued (2023 - 2025)

Fractyl Health (GUTS) has disclosed Shares Issued for 3 consecutive years, with -$280000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued changed N/A year-over-year to -$280000.0, compared with a TTM value of -$103.1 million through Sep 2025, down 199.43%, and an annual FY2024 reading of $572000.0, up 1000.0% over the prior year.
  • Shares Issued was -$280000.0 for Q3 2025 at Fractyl Health, down from $280000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $103.7 million in Q1 2024 and bottomed at -$103.1 million in Q4 2024.
  • Average Shares Issued over 3 years is $99000.0, with a median of $11000.0 recorded in 2023.
  • The sharpest move saw Shares Issued plummeted 606705.88% in 2024, then plummeted 99.73% in 2025.
  • Year by year, Shares Issued stood at $17000.0 in 2023, then tumbled by 606705.88% to -$103.1 million in 2024, then surged by 99.73% to -$280000.0 in 2025.
  • Business Quant data shows Shares Issued for GUTS at -$280000.0 in Q3 2025, $280000.0 in Q1 2025, and -$103.1 million in Q4 2024.